| ANIXA BIOSCIENCES DL -,01 |
| USA |
| Gesundheit |
| US03528H1095 / A2N6ZF |
| CY71 (Frankfurt) / ANIX (NASDAQ) |
| FRA:CY71, ETR:CY71, CY71:GR, NASDAQ:ANIX |
| - |
| https://www.anixa.com/ |
|
Anixa Biosciences Inc. is a biotechnology company ..
>Volltext.. |
| 91.97 Mio. EUR |
| 78.04 Mio. EUR |
| - |
| -9.86 Mio. EUR |
| -9.24 Mio. EUR |
| -0.28 EUR |
| 0.17 Mio. EUR |
| 1.05 Mio. EUR |
| -6.06 Mio. EUR |
| 7.71 |
| - |
| 17.9% |
| - |
| - |
| - |
| - |
| ANIXA BIOSCIENCES, ANIXA BIOSCIENCE, ANIXA BIO |
| 27.01.26 |